CYRX Cryoport Inc: Price-to-Projected Revenue Ratio

Corporate emblem and logo of Cryoport Inc (CYRX)

Cryoport, Inc. (CYRX) leads the deep-frozen IT logistics sector, benefiting from the growth of gene therapy. The forward P/S ratio clearly demonstrates the impact of central bank policy on the asset's valuation, where the value 5.30 describes the current level. The company is building a B2B ecosystem, controlling the delivery of live cells in accordance with FDA regulations. Specialized nitrogen containers guarantee the preservation of biomaterials, ensuring absolute reliability of supply chains.

CYRX Cryoport: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/13/2026

Analytical breakdowns for Cryoport Corp (CYRX)

- market price and analyst price targets:
Price Chart Cryoport|CYRX - Average Forecast Price
- company stock capitalization data:
Market Value Cryoport Corp|CYRX - Full Business Value
- book value of equity indicators:
Net Assets per Single Share Cryoport|CYRX - Total Stockholders' Equity|Market Value to Book Value Ratio cryoport.com|CYRX - Aggregate Asset Value
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Cryoport, Inc.|CYRX - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio Cryoport, Inc.|CYRX - Aggregate Debt Obligations|Debts to Book Capitalization Cryoport Corp|CYRX - Long-Term Debt Volume|Company Short-Term Debt Cryoport|Quick Ratio cryoport.com
- business earnings and investment ratios data:
CYRX - Net Income|Future Profit Cryoport, Inc.|CYRX - Business Payback Period|Forward P/E Multiple Cryoport Systems|CYRX - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Cryoport Corp|CYRX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Cryoport|CYRX - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months cryoport.com|CYRX - Earnings per share growth this year|Net earnings per share growth forecast for next year Cryoport, Inc.
- revenue and sales details:
CYRX - Company Revenue|Company Projected Revenue Cryoport|CYRX - Price to Sales|Forward P/S Multiple Cryoport Corp
Summary company analysis:Cryoport CYRX
Manufactured products of cryoport.com

The specifics of Cryoport, Inc. (CYRX) are based on its monopoly over cryogenic technologies and strict government regulation, which create an insurmountable barrier to entry for competitors. The forward P/S trend compares the asset's current market value with expected revenue, allowing investors to determine the extent of the premium paid for future earnings or to identify a point of undervaluation for the company given its fundamental advantages.

Analysis of competing companies

Price-to-Projected Revenue Ratio Symbotic SYM|Manhattan Associates Inc (MANH) - Market Cap to Future Revenue Ratio|JBHT - Price-to-Projected Revenue Ratio|Future Price to Revenue YMM|descartes.com (DSGX) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio GXO Logistics (GXO)|Price-to-Projected Revenue Ratio Xometry|KARO: Forward Price to Sales|Forward Price-to-Revenue Multiple GCT (GigaCloud)|Price to Expected Revenue Ratio AIOT|Reitar Logtech Holdings Ltd - Forward Price-to-Revenue Multiple|Forward Price to Sales PKOH|ReposiTrak - Forward P/S Multiple|Market Cap to Expected Sales Ratio Freightos Limited CRGO|Arrive AI Corp (ARAI) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue SFWL|MYSZ (My Size, Inc.) - Forward P/S Multiple|Forward Price-to-Revenue Multiple fr8technologies.com (FRGT)|Forward Price-to-Revenue Multiple YAAS (Youxin Technology)|Market Cap to Expected Sales Ratio SMX (Security Matters) Public Limited Company|Forward P/S Multiple BEST (BEST Logistics)|ETWO - Forward Price-to-Revenue Multiple|STCN: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio WaveDancer, Inc.